JackWHsuMD
Hematology • Gainesville, FLAssistant Professor, Medicine, University of Florida College of Medicine
Dr. Hsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Sw Archer Rd
Gainesville, FL 32610Phone+1 352-392-3000Fax+1 352-392-8530
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 1998 - 2001- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1995 - 1998
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
FL State Medical License 2007 - 2025
NJ State Medical License 1997 - 2007
PA State Medical License 1998 - 1998- American Board of Internal Medicine Hematology
Clinical Trials
- Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation Start of enrollment: 2011 Apr 01
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Publications & Presentations
PubMed
- 297 citationsIncreasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He
Biology of Blood and Marrow Transplantation. 2015-02-01 - 8 citationsOpen-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myel...Pinkal Desai, Janice M. Brown, Saar Gill, Melham M. Solh, Luke P. Akard
Journal of Clinical Oncology. 2021-06-22 - 44 citationsMetabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZachariah DeFilipp, R. F. Duarte, John A. Snowden, Navneet S. Majhail, Diana Greenfield
Bone Marrow Transplantation. 2017-02-01
Journal Articles
- Pharmacokinetic and Clinical Outcomes When Ideal Body Weight Is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant RecipientsJack W Hsu, Hemant S Murthy, Nature
Abstracts/Posters
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Jack W. Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) SurvivorsJack W. Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Lower Hematopoietic Progenitor Cell Counts and Yields at Subsequent Donations Is Influenced By a Shorter Inter-Donation Interval between the First and Subsequent Mobil...Jack W. Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Weighty Choices: Selecting Optimal G-CSF Doses for Stem Cell Mobilization to Optimize Yield2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
